flupenthixol-decanoate and Body-Weight

flupenthixol-decanoate has been researched along with Body-Weight* in 2 studies

Trials

2 trial(s) available for flupenthixol-decanoate and Body-Weight

ArticleYear
[Incidence of rigor during treatment with flupentixol decanoate in comparison to risperidone].
    Psychiatrische Praxis, 2004, Volume: 31 Suppl 1

    We investigated as to whether dosedependent extrapyramidal tolerance of Flupentixol decanoate is inferior to that of Risperidone.. 143 Risperidone and 177 Flupentixol decanoate treated patients were consecutively entered into this non - randomized open study and assessed with the Simpson-Angus-Scale regarding presence of rigor. Treatment comparisons of rigor frequency was done by Kaplan-Meier analysis.. The risk of rigor increased with dose on both treatments. EPMS-risk was not increased under treatment with Flupentixol decanoate (mean dose 35.06 +/- 19.7 mg/2 weeks) compared to Risperidone (mean daily dose: 5.2 +/- 2.5 mg/kg) when comparable weight standardized Haloperidol equivalence doses (WHE) were used.. This study offers limited evidence for methodological reasons. Yet, results do not support the view that EPS are more frequent on Flupentixol decanoate than on Risperidone when doses are comparable.

    Topics: Adult; Analysis of Variance; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Flupenthixol; Haloperidol; Humans; Incidence; Male; Middle Aged; Muscle Rigidity; Neurologic Examination; Prospective Studies; Risperidone

2004
Chronic dopamine antagonism facilitates opiate-induced feeding.
    Journal of psychiatry & neuroscience : JPN, 1995, Volume: 20, Issue:3

    Chronic interference with dopamine (DA) transmission has been found to facilitate opiate reward and opiate-induced behavioral activation derived from the nucleus accumbens. This study was aimed at determining the extent to which these effects are generalizable to opiate-induced feeding. Rats were tested for their feeding response to morphine following chronic interference with DAergic transmission with the long-acting neuroleptic, flupenthixol decanoate (FLU). It was found that FLU-treated animals showed an enhanced feeding response to morphine following three and four weeks of DA blockade, but not on weeks 1 and 2. Neither morphine treatment in FLU-control animals nor chronic FLU treatment alone produced any such time-dependent facilitation in feeding. The results indicate that the increased sensitivity to the rewarding effects of opiates following chronic DA blockade is generalizable to opiate-induced feeding.

    Topics: Animals; Body Weight; Dopamine; Dopamine Antagonists; Drug Synergism; Eating; Flupenthixol; Male; Morphine; Rats; Rats, Wistar; Weight Gain

1995